MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10147-020-01763-1

Медицинская библиотека · International journal of clinical oncology · 2020

Oxaliplatin-induced increase in splenic volume: experiences from multicenter study in Japan.

Ohta Ryo, Yamada Takeshi, Hara Keisuke, Iwai Takuma, Tanakaya Kohji, Ishibashi Keiichiro, Yoshimatsu Kazuhiko, Kosugi Chihiro, Tsubaki Masahiro, Nakajima Hideo, Oya Masatoshi, Yoshida Hiroshi, Koda Keiji, Ishida Hideyuki

Клиническое исследование II фазыСтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Chemotherapy with oxaliplatin is known to induce sinusoidal obstruction syndrome (SOS). In a previous single-center study, we reported that oxaliplatin-induced increase in splenic volume (SV) is strongly indicative of SOS, and that this increase in SV persisted for > 1 year after completing chemotherapy. The aim of this study was to confirm the oxaliplatin-induced SV change in a multicenter study in patients with stage III colon cancer in Japan.

METHODS

We enrolled 59 patients who underwent curative resection for stage III colon cancer in the FACOS study in a phase II multi-center clinical study. Participants received mFOLFOX6 or CAPOX as adjuvant chemotherapy. SV change was assessed three times by computed tomographic volumetry: before surgery, on completion of adjuvant chemotherapy, and 1 year after completing adjuvant chemotherapy.

RESULTS

SV on completing and 1 year after chemotherapy was significantly higher than that before surgery (P < 0.001). Oxaliplatin-induced SOS persisted for > 1 year after the completion of adjuvant chemotherapy in half of the patients. There was no difference in 3-year disease-free survival with respect to the presence or absence of increased SV. An increase in SV was observed in 72% of patients treated with mFOLFOX6 and 94% of patients treated with CAPOX (P = 0.13).

CONCLUSION

This study can be verified the findings observed in our previous single-center study, oxaliplatin-based adjuvant chemotherapy was associated with an increase in SV. Furthermore, this increase can persist for > 1 year. The continuous presence of SOS may have a negative impact on prognosis in patients that develop recurrent disease.

Для цитирования: Ohta Ryo, Yamada Takeshi, Hara Keisuke, Iwai Takuma, Tanakaya Kohji, Ishibashi Keiichiro, Yoshimatsu Kazuhiko, Kosugi Chihiro, Tsubaki Masahiro, Nakajima Hideo, Oya Masatoshi, Yoshida Hiroshi, Koda Keiji, Ishida Hideyuki. Oxaliplatin-induced increase in splenic volume: experiences from multicenter study in Japan.. International journal of clinical oncology. 2020. DOI: 10.1007/s10147-020-01763-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.